Skip to main content

Table 4 The effect of HIV infection and different types of antiretroviral therapy, on markers of oxidative stress (carbonyls and TBARs).

From: The effect of different combination therapies on oxidative stress markers in HIV infected patients in cameroon

  HIV- HIV+
Groups Control (n = 90) pre-HAART (n = 65) Therapy I (n = 40) Therapy II (n = 20) Therapy III (n = 25)
Carbonyls (nmol/mg) 1.07 ± 0.27 1.34 ± 0.98a 0.79 ± 0.10ab 0.93 ± 0.16b 0.81 ± 0.09ab
TBARS (μmol/l) 1.30 ± 0.12 4.20 ± 0.70a 7.02 ± 2.58ab 5.92 ± 1.46ab 5.84 ± 0.89ab
  1. Significant differences (a P < 0.01) are by comparison with the control group (HIV Negative), (b P < 0.001) are by comparison with the HIV positive patients without therapy (pre-HAART)